IRIS
LOGROSCINO, Giancarlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.387
EU - Europa 4.462
AS - Asia 3.086
AF - Africa 203
OC - Oceania 92
SA - Sud America 74
Continente sconosciuto - Info sul continente non disponibili 10
Totale 31.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.297
CN - Cina 1.394
SE - Svezia 1.024
IT - Italia 651
UA - Ucraina 588
DE - Germania 556
GB - Regno Unito 480
FI - Finlandia 356
HK - Hong Kong 295
IN - India 252
FR - Francia 251
IR - Iran 185
KR - Corea 155
IE - Irlanda 113
NL - Olanda 110
VN - Vietnam 105
BE - Belgio 99
SG - Singapore 99
TW - Taiwan 93
PK - Pakistan 79
MY - Malesia 70
AU - Australia 68
TR - Turchia 68
CA - Canada 65
JP - Giappone 60
RU - Federazione Russa 57
BR - Brasile 49
ET - Etiopia 37
BD - Bangladesh 34
ID - Indonesia 33
IQ - Iraq 30
NG - Nigeria 30
CH - Svizzera 27
ZA - Sudafrica 27
PH - Filippine 26
EG - Egitto 24
NZ - Nuova Zelanda 24
AE - Emirati Arabi Uniti 21
RO - Romania 21
SA - Arabia Saudita 21
NO - Norvegia 20
PL - Polonia 19
GH - Ghana 18
ES - Italia 16
MX - Messico 14
PT - Portogallo 14
TH - Thailandia 14
AT - Austria 12
IL - Israele 11
MA - Marocco 11
BW - Botswana 9
CO - Colombia 9
DK - Danimarca 9
EU - Europa 9
GR - Grecia 9
BN - Brunei Darussalam 8
EC - Ecuador 7
LY - Libia 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
KE - Kenya 5
MM - Myanmar 5
NP - Nepal 5
AL - Albania 4
CL - Cile 4
LK - Sri Lanka 4
NI - Nicaragua 4
RS - Serbia 4
TN - Tunisia 4
ZM - Zambia 4
BG - Bulgaria 3
BH - Bahrain 3
BT - Bhutan 3
CR - Costa Rica 3
GA - Gabon 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
BF - Burkina Faso 2
BJ - Benin 2
CM - Camerun 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
LS - Lesotho 2
LT - Lituania 2
NA - Namibia 2
PE - Perù 2
RW - Ruanda 2
SO - Somalia 2
TD - Ciad 2
UG - Uganda 2
VE - Venezuela 2
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GM - Gambi 1
GT - Guatemala 1
Totale 31.303
Salva come PNG Salva come JPEG
Città #
Fairfield 3.742
Woodbridge 2.501
Houston 2.046
Chandler 1.947
Ashburn 1.861
Seattle 1.544
Jacksonville 1.386
Cambridge 1.298
Wilmington 1.202
Ann Arbor 916
Nyköping 735
Lawrence 443
Roxbury 434
Nanjing 359
Beijing 329
Des Moines 303
New York 225
San Diego 150
Hong Kong 143
Boardman 142
Princeton 135
Bari 121
Dublin 103
Dearborn 100
Nanchang 96
Brooklyn 95
Shenyang 88
Dong Ket 86
Paris 85
Hebei 83
Brussels 81
Inglewood 78
Jiaxing 74
London 72
Singapore 63
Central 60
Kuala Lumpur 58
Los Angeles 57
Tianjin 57
Changsha 52
Taranto 49
Norwalk 45
Redwood City 45
Tehran 39
Pune 38
Ruvo Di Puglia 38
Washington 38
Strasbourg 35
Hefei 29
Taipei 29
San Mateo 27
Guangzhou 24
Ostuni 24
Augusta 23
Jinan 23
Ardabil 22
Melbourne 22
Tokyo 22
Auburn Hills 21
Falls Church 21
Leeds 21
Mumbai 21
New Taipei 21
Berlin 20
Helsinki 20
Istanbul 20
Milan 20
San Francisco 19
Lahore 18
Leawood 18
Nowon-gu 18
Sulaymaniyah 18
Accra 17
Dhaka 17
San Jose 17
Coventry 16
Hyderabad 16
Kunming 16
Liverpool 16
St Louis 16
Chicago 15
Isfahan 15
Toronto 15
Geneva 14
Islamabad 14
Jeddah 14
Pont-Sainte-Marie 14
Seodaemun-gu 14
Southwark 14
Sydney 14
Dubai 13
Giza 13
Ningbo 13
Scottsdale 13
Zhengzhou 13
Delhi 12
Edinburgh 12
Faisalabad 12
Groningen 12
Manchester 12
Totale 24.597
Salva come PNG Salva come JPEG
Nome #
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 2.701
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 256
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 189
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 164
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 164
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 155
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 142
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 138
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 133
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 129
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 127
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid 1–42 measurement 127
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 124
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 124
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 123
Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease. Alzheimer's Disease. 122
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 121
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial 120
Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects 116
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort 115
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 114
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 114
Plasma β-amyloid 1–42 reference values in cognitively normal subjects 114
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres 113
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 112
Unreported financial disclosures in a study of migraine and cardiovascular disease 111
COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis 111
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 109
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 107
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 107
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition in Older Age 106
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 105
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 105
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 104
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 104
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 104
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 103
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 103
Bioelectrical correlates of emotional changes induced by environmental sound and colour: from virtual reality to real life 103
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 102
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 102
null 101
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 101
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 101
Factors predicting survival in ALS: a multicenter Italian study 101
null 100
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke 100
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 99
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 99
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 98
Epidemiology of age related hearing loss: A review 98
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 98
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 98
Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis 98
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 97
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. 97
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 96
null 95
The age-related central auditory processing disorder: Silent impairment of the cognitive ear 95
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 95
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy 94
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis 93
Cognitive frailty: a potential target for secondary prevention of dementia 93
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 93
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 91
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: Clinical validity and psychometric properties 91
Epidemiology of neurodegenerative diseases 91
Metabolic syndrome, mild cognitive impairment, and dementia 90
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 90
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 89
Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links 88
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 88
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 87
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 86
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 86
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 86
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 86
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 86
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 85
Environmental risk factors for Parkinson's disease in an urban multiethnic community 84
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 84
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 84
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 84
The ever-stimulating association of smoking and coffee and Parkinson's disease 83
null 83
null 83
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 83
A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy 83
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis 83
Classification of healthy subjects and Alzheimer's disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks 83
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 83
Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis 83
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 82
Bipolar disorder and frontotemporal dementia: An intriguing association 82
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 82
Migraine and risk of cardiovascular disease in women 81
Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis 81
Verbal Learning Abilities in ALS Patients (P01.109) 81
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 81
Folate intake and risk of Parkinson's disease 80
Totale 12.936
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.166 0 0 0 0 0 0 0 0 0 0 1.121 1.045
2019/20208.877 1.295 490 272 780 1.023 628 933 886 1.126 490 718 236
2020/20215.807 398 343 407 555 647 396 831 440 468 641 361 320
2021/20222.961 148 180 21 133 166 347 78 158 251 215 434 830
2022/20234.767 721 477 305 432 561 553 97 573 798 38 136 76
2023/20244.269 347 630 359 336 427 1.103 485 440 89 44 9 0
Totale 32.657